Drug-Eluting Balloon-United States Market Status and Trend Report 2013-2023
Report Summary
Drug-Eluting Balloon-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Drug-Eluting Balloon industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Drug-Eluting Balloon 2013-2017, and development forecast 2018-2023
Main market players of Drug-Eluting Balloon in United States, with company and product introduction, position in the Drug-Eluting Balloon market
Market status and development trend of Drug-Eluting Balloon by types and applications
Cost and profit status of Drug-Eluting Balloon, and marketing status
Market growth drivers and challenges
The report segments the United States Drug-Eluting Balloon market as:
United States Drug-Eluting Balloon Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Drug-Eluting Balloon Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Type I
Type II
United States Drug-Eluting Balloon Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Treatment of In-stent Restenosis (ISR)
Treatment of Small Vessel Disease (SVD)
Treatment of Bifurcation Stenoses
Treatment of Primary Coronary Artery Disease
United States Drug-Eluting Balloon Market: Players Segment Analysis (Company and Product introduction, Drug-Eluting Balloon Sales Volume, Revenue, Price and Gross Margin):
Boston Scientific
Medtronic
Cook Medical
C.R. Bard
B. Braun
Eurocor GmbH
Blue Medical
Bayer
Aachen Resonance
Acrostak
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Drug-Eluting Balloon-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Drug-Eluting Balloon industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Drug-Eluting Balloon 2013-2017, and development forecast 2018-2023
Main market players of Drug-Eluting Balloon in United States, with company and product introduction, position in the Drug-Eluting Balloon market
Market status and development trend of Drug-Eluting Balloon by types and applications
Cost and profit status of Drug-Eluting Balloon, and marketing status
Market growth drivers and challenges
The report segments the United States Drug-Eluting Balloon market as:
United States Drug-Eluting Balloon Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Drug-Eluting Balloon Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Type I
Type II
United States Drug-Eluting Balloon Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Treatment of In-stent Restenosis (ISR)
Treatment of Small Vessel Disease (SVD)
Treatment of Bifurcation Stenoses
Treatment of Primary Coronary Artery Disease
United States Drug-Eluting Balloon Market: Players Segment Analysis (Company and Product introduction, Drug-Eluting Balloon Sales Volume, Revenue, Price and Gross Margin):
Boston Scientific
Medtronic
Cook Medical
C.R. Bard
B. Braun
Eurocor GmbH
Blue Medical
Bayer
Aachen Resonance
Acrostak
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF DRUG-ELUTING BALLOON
1.1 Definition of Drug-Eluting Balloon in This Report
1.2 Commercial Types of Drug-Eluting Balloon
1.2.1 Type I
1.2.2 Type II
1.3 Downstream Application of Drug-Eluting Balloon
1.3.1 Treatment of In-stent Restenosis (ISR)
1.3.2 Treatment of Small Vessel Disease (SVD)
1.3.3 Treatment of Bifurcation Stenoses
1.3.4 Treatment of Primary Coronary Artery Disease
1.4 Development History of Drug-Eluting Balloon
1.5 Market Status and Trend of Drug-Eluting Balloon 2013-2023
1.5.1 United States Drug-Eluting Balloon Market Status and Trend 2013-2023
1.5.2 Regional Drug-Eluting Balloon Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Drug-Eluting Balloon in United States 2013-2017
2.2 Consumption Market of Drug-Eluting Balloon in United States by Regions
2.2.1 Consumption Volume of Drug-Eluting Balloon in United States by Regions
2.2.2 Revenue of Drug-Eluting Balloon in United States by Regions
2.3 Market Analysis of Drug-Eluting Balloon in United States by Regions
2.3.1 Market Analysis of Drug-Eluting Balloon in New England 2013-2017
2.3.2 Market Analysis of Drug-Eluting Balloon in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Drug-Eluting Balloon in The Midwest 2013-2017
2.3.4 Market Analysis of Drug-Eluting Balloon in The West 2013-2017
2.3.5 Market Analysis of Drug-Eluting Balloon in The South 2013-2017
2.3.6 Market Analysis of Drug-Eluting Balloon in Southwest 2013-2017
2.4 Market Development Forecast of Drug-Eluting Balloon in United States 2018-2023
2.4.1 Market Development Forecast of Drug-Eluting Balloon in United States 2018-2023
2.4.2 Market Development Forecast of Drug-Eluting Balloon by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Drug-Eluting Balloon in United States by Types
3.1.2 Revenue of Drug-Eluting Balloon in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Drug-Eluting Balloon in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Drug-Eluting Balloon in United States by Downstream Industry
4.2 Demand Volume of Drug-Eluting Balloon by Downstream Industry in Major Countries
4.2.1 Demand Volume of Drug-Eluting Balloon by Downstream Industry in New England
4.2.2 Demand Volume of Drug-Eluting Balloon by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Drug-Eluting Balloon by Downstream Industry in The Midwest
4.2.4 Demand Volume of Drug-Eluting Balloon by Downstream Industry in The West
4.2.5 Demand Volume of Drug-Eluting Balloon by Downstream Industry in The South
4.2.6 Demand Volume of Drug-Eluting Balloon by Downstream Industry in Southwest
4.3 Market Forecast of Drug-Eluting Balloon in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF DRUG-ELUTING BALLOON
5.1 United States Economy Situation and Trend Overview
5.2 Drug-Eluting Balloon Downstream Industry Situation and Trend Overview
CHAPTER 6 DRUG-ELUTING BALLOON MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Drug-Eluting Balloon in United States by Major Players
6.2 Revenue of Drug-Eluting Balloon in United States by Major Players
6.3 Basic Information of Drug-Eluting Balloon by Major Players
6.3.1 Headquarters Location and Established Time of Drug-Eluting Balloon Major Players
6.3.2 Employees and Revenue Level of Drug-Eluting Balloon Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 DRUG-ELUTING BALLOON MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Boston Scientific
7.1.1 Company profile
7.1.2 Representative Drug-Eluting Balloon Product
7.1.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Boston Scientific
7.2 Medtronic
7.2.1 Company profile
7.2.2 Representative Drug-Eluting Balloon Product
7.2.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Medtronic
7.3 Cook Medical
7.3.1 Company profile
7.3.2 Representative Drug-Eluting Balloon Product
7.3.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Cook Medical
7.4 C.R. Bard
7.4.1 Company profile
7.4.2 Representative Drug-Eluting Balloon Product
7.4.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of C.R. Bard
7.5 B. Braun
7.5.1 Company profile
7.5.2 Representative Drug-Eluting Balloon Product
7.5.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of B. Braun
7.6 Eurocor GmbH
7.6.1 Company profile
7.6.2 Representative Drug-Eluting Balloon Product
7.6.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Eurocor GmbH
7.7 Blue Medical
7.7.1 Company profile
7.7.2 Representative Drug-Eluting Balloon Product
7.7.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Blue Medical
7.8 Bayer
7.8.1 Company profile
7.8.2 Representative Drug-Eluting Balloon Product
7.8.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Bayer
7.9 Aachen Resonance
7.9.1 Company profile
7.9.2 Representative Drug-Eluting Balloon Product
7.9.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Aachen Resonance
7.10 Acrostak
7.10.1 Company profile
7.10.2 Representative Drug-Eluting Balloon Product
7.10.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Acrostak
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DRUG-ELUTING BALLOON
8.1 Industry Chain of Drug-Eluting Balloon
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF DRUG-ELUTING BALLOON
9.1 Cost Structure Analysis of Drug-Eluting Balloon
9.2 Raw Materials Cost Analysis of Drug-Eluting Balloon
9.3 Labor Cost Analysis of Drug-Eluting Balloon
9.4 Manufacturing Expenses Analysis of Drug-Eluting Balloon
CHAPTER 10 MARKETING STATUS ANALYSIS OF DRUG-ELUTING BALLOON
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Drug-Eluting Balloon in This Report
1.2 Commercial Types of Drug-Eluting Balloon
1.2.1 Type I
1.2.2 Type II
1.3 Downstream Application of Drug-Eluting Balloon
1.3.1 Treatment of In-stent Restenosis (ISR)
1.3.2 Treatment of Small Vessel Disease (SVD)
1.3.3 Treatment of Bifurcation Stenoses
1.3.4 Treatment of Primary Coronary Artery Disease
1.4 Development History of Drug-Eluting Balloon
1.5 Market Status and Trend of Drug-Eluting Balloon 2013-2023
1.5.1 United States Drug-Eluting Balloon Market Status and Trend 2013-2023
1.5.2 Regional Drug-Eluting Balloon Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Drug-Eluting Balloon in United States 2013-2017
2.2 Consumption Market of Drug-Eluting Balloon in United States by Regions
2.2.1 Consumption Volume of Drug-Eluting Balloon in United States by Regions
2.2.2 Revenue of Drug-Eluting Balloon in United States by Regions
2.3 Market Analysis of Drug-Eluting Balloon in United States by Regions
2.3.1 Market Analysis of Drug-Eluting Balloon in New England 2013-2017
2.3.2 Market Analysis of Drug-Eluting Balloon in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Drug-Eluting Balloon in The Midwest 2013-2017
2.3.4 Market Analysis of Drug-Eluting Balloon in The West 2013-2017
2.3.5 Market Analysis of Drug-Eluting Balloon in The South 2013-2017
2.3.6 Market Analysis of Drug-Eluting Balloon in Southwest 2013-2017
2.4 Market Development Forecast of Drug-Eluting Balloon in United States 2018-2023
2.4.1 Market Development Forecast of Drug-Eluting Balloon in United States 2018-2023
2.4.2 Market Development Forecast of Drug-Eluting Balloon by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Drug-Eluting Balloon in United States by Types
3.1.2 Revenue of Drug-Eluting Balloon in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Drug-Eluting Balloon in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Drug-Eluting Balloon in United States by Downstream Industry
4.2 Demand Volume of Drug-Eluting Balloon by Downstream Industry in Major Countries
4.2.1 Demand Volume of Drug-Eluting Balloon by Downstream Industry in New England
4.2.2 Demand Volume of Drug-Eluting Balloon by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Drug-Eluting Balloon by Downstream Industry in The Midwest
4.2.4 Demand Volume of Drug-Eluting Balloon by Downstream Industry in The West
4.2.5 Demand Volume of Drug-Eluting Balloon by Downstream Industry in The South
4.2.6 Demand Volume of Drug-Eluting Balloon by Downstream Industry in Southwest
4.3 Market Forecast of Drug-Eluting Balloon in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF DRUG-ELUTING BALLOON
5.1 United States Economy Situation and Trend Overview
5.2 Drug-Eluting Balloon Downstream Industry Situation and Trend Overview
CHAPTER 6 DRUG-ELUTING BALLOON MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Drug-Eluting Balloon in United States by Major Players
6.2 Revenue of Drug-Eluting Balloon in United States by Major Players
6.3 Basic Information of Drug-Eluting Balloon by Major Players
6.3.1 Headquarters Location and Established Time of Drug-Eluting Balloon Major Players
6.3.2 Employees and Revenue Level of Drug-Eluting Balloon Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 DRUG-ELUTING BALLOON MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Boston Scientific
7.1.1 Company profile
7.1.2 Representative Drug-Eluting Balloon Product
7.1.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Boston Scientific
7.2 Medtronic
7.2.1 Company profile
7.2.2 Representative Drug-Eluting Balloon Product
7.2.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Medtronic
7.3 Cook Medical
7.3.1 Company profile
7.3.2 Representative Drug-Eluting Balloon Product
7.3.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Cook Medical
7.4 C.R. Bard
7.4.1 Company profile
7.4.2 Representative Drug-Eluting Balloon Product
7.4.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of C.R. Bard
7.5 B. Braun
7.5.1 Company profile
7.5.2 Representative Drug-Eluting Balloon Product
7.5.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of B. Braun
7.6 Eurocor GmbH
7.6.1 Company profile
7.6.2 Representative Drug-Eluting Balloon Product
7.6.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Eurocor GmbH
7.7 Blue Medical
7.7.1 Company profile
7.7.2 Representative Drug-Eluting Balloon Product
7.7.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Blue Medical
7.8 Bayer
7.8.1 Company profile
7.8.2 Representative Drug-Eluting Balloon Product
7.8.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Bayer
7.9 Aachen Resonance
7.9.1 Company profile
7.9.2 Representative Drug-Eluting Balloon Product
7.9.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Aachen Resonance
7.10 Acrostak
7.10.1 Company profile
7.10.2 Representative Drug-Eluting Balloon Product
7.10.3 Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin of Acrostak
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DRUG-ELUTING BALLOON
8.1 Industry Chain of Drug-Eluting Balloon
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF DRUG-ELUTING BALLOON
9.1 Cost Structure Analysis of Drug-Eluting Balloon
9.2 Raw Materials Cost Analysis of Drug-Eluting Balloon
9.3 Labor Cost Analysis of Drug-Eluting Balloon
9.4 Manufacturing Expenses Analysis of Drug-Eluting Balloon
CHAPTER 10 MARKETING STATUS ANALYSIS OF DRUG-ELUTING BALLOON
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
